Streetbeat News

Products Services

COHR

Coherent Corp. has announced the release of the industry's first 100G ZR QSFP28 digital coherent optics transceiver that operates over a wide industrial temperature range. This product launch could enhance Coherent's market position in optical networking solutions.

Portfolio Pulse from

December 09, 2024 | 9:45 pm

AI

C3.ai has increased its revenue forecast for fiscal year 2025 due to strong demand for its enterprise AI software, as companies seek tools to streamline workflows.

Portfolio Pulse from

December 09, 2024 | 9:45 pm

OLN

Olin Corporation is hosting an Investor Day on December 12, 2024, from 9:00 am to 12:00 pm ET. This event is an opportunity for investors to gain insights into the company's strategies and future plans.

Portfolio Pulse from

December 09, 2024 | 9:45 pm

GLD

The SPDR Gold Trust (GLD) celebrates its 20th anniversary. State Street Global Advisors' Chief Gold Strategist, George Milling-Stanley, emphasizes that Bitcoin does not provide the same protections as gold.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

BLND

Blend Labs, Inc. has appointed Srini Venkatramani as Head of Product, Technology, and Customer Operations to drive growth in digital banking solutions. Srini brings over 23 years of experience in scaling SaaS businesses and product innovation.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

RLY

Relay Therapeutics is set to present updated clinical data on its RLY-2608 treatment for HR+/HER2- breast cancer at the 2024 San Antonio Breast Cancer Symposium. The company will also host a conference call on December 11, 2024, to discuss the findings.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

PL

Planet Labs PBC has announced the arrival of its latest high-resolution satellite, Pelican-2, and 36 SuperDoves at Vandenberg Space Force Base. These are set to launch in early 2025 on SpaceX's Transporter-12 Rideshare mission.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

CPIX

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced FDA approval for a supplemental New Drug Application (sNDA) for Acetadote®, simplifying its dosing regimen.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

NBTX

Nanobiotix has completed a Phase 1 study of its nanoparticle-based therapy, NBTXR3 (JNJ-1900), for pancreatic cancer. The study was conducted by MD Anderson Cancer Center and focused on dose escalation and expansion for locally advanced and borderline resectable pancreatic cancer.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

PHR

Phreesia, Inc. (NYSE: PHR) announced its fiscal third quarter results for 2025, highlighting growth in its network and increased adoption of its offerings. The company is optimistic about its future and new solutions.

Portfolio Pulse from

December 09, 2024 | 9:30 pm